Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial
Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage, Neurological Research and Practice
Use of direct oral anticoagulants in ICU patients. Part II – Clinical evidence
Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage - Eilertsen, H - 2023
MORE
Incidence Rate of ICH per 100 000 Person-years
Protocol for management of bleeding events in patients receiving
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial - The Lancet
Full article: Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
Tranexamic Acid for Intracerebral Haemorrhage in Patients on NOAC
Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials - Zhe Kang Law, Atte Meretoja, Stefan T Engelter, Hanne Christensen, Eugenia-Maria Muresan, Solveig B Glad
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor–Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care
Acute Treatment of Intracerebral Haemorrhage (Chapter 13) - Stroke Prevention and Treatment
